US Stock MarketDetailed Quotes

XRTX XORTX Therapeutics

Watchlist
  • 1.5400
  • +0.0099+0.65%
Close Oct 4 16:00 ET
  • 1.6999
  • +0.1599+10.38%
Post 18:58 ET
4.47MMarket Cap-4162P/E (TTM)

XORTX Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-15.21%1.49M
-42.92%1.09M
-41.25%6.05M
-63.02%983.67K
-33.75%1.39M
-33.56%1.76M
-33.68%1.91M
253.56%10.29M
102.94%2.66M
562.59%2.1M
Selling and administrative expenses
13.24%817.91K
0.33%512.15K
-7.13%2.23M
-4.86%484.85K
5.75%510.11K
-0.69%722.3K
-24.89%510.46K
48.43%2.4M
-30.15%509.6K
547.72%482.37K
-General and administrative expense
13.24%817.91K
0.33%512.15K
-7.13%2.23M
-4.86%484.85K
5.75%510.11K
-0.69%722.3K
-24.89%510.46K
48.43%2.4M
-30.15%509.6K
547.72%482.37K
Research and development costs
-89.87%67.68K
-92.97%73.64K
-64.23%2.42M
-92.95%134.13K
-61.32%569.71K
-54.19%667.91K
-45.69%1.05M
897.94%6.76M
449.11%1.9M
391.84%1.47M
Depreciation amortization depletion
3.21%33.05K
-51.93%32.13K
140.25%139.69K
7.99%24.36K
-25.34%16.47K
228.21%32.02K
1,670.31%66.85K
307.58%58.15K
469.33%22.56K
521.62%22.06K
-Depreciation and amortization
3.21%33.05K
-51.93%32.13K
140.25%139.69K
7.99%24.36K
-25.34%16.47K
228.21%32.02K
1,670.31%66.85K
307.58%58.15K
469.33%22.56K
521.62%22.06K
Other operating expenses
69.40%575.05K
66.30%470.7K
17.55%1.26M
51.59%340.34K
135.93%297.02K
-25.63%339.47K
6.84%283.03K
77.87%1.07M
-2.63%224.51K
3.07%125.9K
Operating profit
15.21%-1.49M
42.92%-1.09M
41.25%-6.05M
63.02%-983.67K
33.75%-1.39M
33.56%-1.76M
33.68%-1.91M
-253.56%-10.29M
-102.94%-2.66M
-562.59%-2.1M
Net non-operating interest income expense
-50.96%35.95K
-52.69%31.6K
144.76%253.54K
-7.26%49.82K
79.40%63.61K
523.19%73.31K
2,421.78%66.8K
2,427.32%103.59K
4,018.84%53.72K
3,372.81%35.46K
Non-operating interest income
-50.96%35.95K
-52.69%31.6K
----
----
79.40%63.61K
523.19%73.31K
2,421.78%66.8K
----
----
--35.46K
Total other finance cost
----
----
-144.76%-253.54K
----
----
----
----
-2,427.32%-103.59K
----
----
Other net income (expense)
46,688.55%1.63M
-23,298.79%-1.96M
47.25%3.63M
13,367.34%3.63M
-100.42%-3.67K
-100.25%-3.49K
-95.01%8.46K
84.77%2.47M
-99.67%26.98K
113.97%870.55K
Gain on sale of security
46,688.55%1.63M
-23,298.79%-1.96M
7.06%3.63M
281.05%3.63M
-100.42%-3.67K
-100.25%-3.49K
-95.01%8.46K
29.37%3.39M
-89.91%953.43K
113.97%870.55K
Special income (charges)
----
----
--0
----
----
----
----
28.08%-926.46K
----
----
-Less：Restructuring and merger&acquisition
----
----
--0
----
----
----
----
-28.08%926.46K
----
----
Income before tax
110.05%170.07K
-64.79%-3.02M
72.04%-2.16M
204.65%2.7M
-11.38%-1.33M
-36.57%-1.69M
32.24%-1.83M
-388.76%-7.72M
-137.68%-2.58M
81.72%-1.2M
Income tax
Net income
110.05%170.07K
-64.79%-3.02M
72.04%-2.16M
204.65%2.7M
-11.38%-1.33M
-36.57%-1.69M
32.24%-1.83M
-388.76%-7.72M
-137.68%-2.58M
81.72%-1.2M
Net income continuous Operations
110.05%170.07K
-64.79%-3.02M
72.04%-2.16M
204.65%2.7M
-11.38%-1.33M
-36.57%-1.69M
32.24%-1.83M
-388.76%-7.72M
-137.68%-2.58M
81.72%-1.2M
Minority interest income
Net income attributable to the parent company
110.05%170.07K
-64.79%-3.02M
72.04%-2.16M
204.65%2.7M
-11.38%-1.33M
-36.57%-1.69M
32.24%-1.83M
-388.76%-7.72M
-137.68%-2.58M
81.72%-1.2M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
110.05%170.07K
-64.79%-3.02M
72.04%-2.16M
204.65%2.7M
-11.38%-1.33M
-36.57%-1.69M
32.24%-1.83M
-388.76%-7.72M
-137.68%-2.58M
81.72%-1.2M
Basic earnings per share
107.06%0.06
-30.53%-1.24
79.12%-1.09
181.90%1.3598
19.28%-0.6699
-4.94%-0.85
49.74%-0.95
-262.50%-5.22
-123.87%-1.6604
86.78%-0.8299
Diluted earnings per share
107.06%0.06
-30.53%-1.24
79.12%-1.09
181.90%1.3598
19.28%-0.6699
-4.94%-0.85
49.74%-0.95
-262.50%-5.22
-123.87%-1.6604
86.78%-0.8299
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -15.21%1.49M-42.92%1.09M-41.25%6.05M-63.02%983.67K-33.75%1.39M-33.56%1.76M-33.68%1.91M253.56%10.29M102.94%2.66M562.59%2.1M
Selling and administrative expenses 13.24%817.91K0.33%512.15K-7.13%2.23M-4.86%484.85K5.75%510.11K-0.69%722.3K-24.89%510.46K48.43%2.4M-30.15%509.6K547.72%482.37K
-General and administrative expense 13.24%817.91K0.33%512.15K-7.13%2.23M-4.86%484.85K5.75%510.11K-0.69%722.3K-24.89%510.46K48.43%2.4M-30.15%509.6K547.72%482.37K
Research and development costs -89.87%67.68K-92.97%73.64K-64.23%2.42M-92.95%134.13K-61.32%569.71K-54.19%667.91K-45.69%1.05M897.94%6.76M449.11%1.9M391.84%1.47M
Depreciation amortization depletion 3.21%33.05K-51.93%32.13K140.25%139.69K7.99%24.36K-25.34%16.47K228.21%32.02K1,670.31%66.85K307.58%58.15K469.33%22.56K521.62%22.06K
-Depreciation and amortization 3.21%33.05K-51.93%32.13K140.25%139.69K7.99%24.36K-25.34%16.47K228.21%32.02K1,670.31%66.85K307.58%58.15K469.33%22.56K521.62%22.06K
Other operating expenses 69.40%575.05K66.30%470.7K17.55%1.26M51.59%340.34K135.93%297.02K-25.63%339.47K6.84%283.03K77.87%1.07M-2.63%224.51K3.07%125.9K
Operating profit 15.21%-1.49M42.92%-1.09M41.25%-6.05M63.02%-983.67K33.75%-1.39M33.56%-1.76M33.68%-1.91M-253.56%-10.29M-102.94%-2.66M-562.59%-2.1M
Net non-operating interest income expense -50.96%35.95K-52.69%31.6K144.76%253.54K-7.26%49.82K79.40%63.61K523.19%73.31K2,421.78%66.8K2,427.32%103.59K4,018.84%53.72K3,372.81%35.46K
Non-operating interest income -50.96%35.95K-52.69%31.6K--------79.40%63.61K523.19%73.31K2,421.78%66.8K----------35.46K
Total other finance cost ---------144.76%-253.54K-----------------2,427.32%-103.59K--------
Other net income (expense) 46,688.55%1.63M-23,298.79%-1.96M47.25%3.63M13,367.34%3.63M-100.42%-3.67K-100.25%-3.49K-95.01%8.46K84.77%2.47M-99.67%26.98K113.97%870.55K
Gain on sale of security 46,688.55%1.63M-23,298.79%-1.96M7.06%3.63M281.05%3.63M-100.42%-3.67K-100.25%-3.49K-95.01%8.46K29.37%3.39M-89.91%953.43K113.97%870.55K
Special income (charges) ----------0----------------28.08%-926.46K--------
-Less：Restructuring and merger&acquisition ----------0-----------------28.08%926.46K--------
Income before tax 110.05%170.07K-64.79%-3.02M72.04%-2.16M204.65%2.7M-11.38%-1.33M-36.57%-1.69M32.24%-1.83M-388.76%-7.72M-137.68%-2.58M81.72%-1.2M
Income tax
Net income 110.05%170.07K-64.79%-3.02M72.04%-2.16M204.65%2.7M-11.38%-1.33M-36.57%-1.69M32.24%-1.83M-388.76%-7.72M-137.68%-2.58M81.72%-1.2M
Net income continuous Operations 110.05%170.07K-64.79%-3.02M72.04%-2.16M204.65%2.7M-11.38%-1.33M-36.57%-1.69M32.24%-1.83M-388.76%-7.72M-137.68%-2.58M81.72%-1.2M
Minority interest income
Net income attributable to the parent company 110.05%170.07K-64.79%-3.02M72.04%-2.16M204.65%2.7M-11.38%-1.33M-36.57%-1.69M32.24%-1.83M-388.76%-7.72M-137.68%-2.58M81.72%-1.2M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 110.05%170.07K-64.79%-3.02M72.04%-2.16M204.65%2.7M-11.38%-1.33M-36.57%-1.69M32.24%-1.83M-388.76%-7.72M-137.68%-2.58M81.72%-1.2M
Basic earnings per share 107.06%0.06-30.53%-1.2479.12%-1.09181.90%1.359819.28%-0.6699-4.94%-0.8549.74%-0.95-262.50%-5.22-123.87%-1.660486.78%-0.8299
Diluted earnings per share 107.06%0.06-30.53%-1.2479.12%-1.09181.90%1.359819.28%-0.6699-4.94%-0.8549.74%-0.95-262.50%-5.22-123.87%-1.660486.78%-0.8299
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data